首页|维奈克拉联合阿扎胞苷对老年急性髓系白血病患者的疗效分析

维奈克拉联合阿扎胞苷对老年急性髓系白血病患者的疗效分析

扫码查看
目的 分析维奈克拉联合阿扎胞苷治疗老年急性髓系白血病患者的临床疗效.方法 将86例老年急性髓系白血病患者采用随机数字表法分组(共两组,每组43例),观察组行维奈克拉联合阿扎胞苷治疗,对照组行阿扎胞苷单独治疗.结果 观察组临床治疗总有效率高于对照组(P<0.05).经治疗观察组患者血小板计数值、白细胞计数值高于对照组;且骨髓原始细胞比例低于对照组(P<0.05).经治疗观察组患者免疫功能指标CD3+、CD4+、CD8+、CD4+/CD8+水平均低于对照组(P<0.05).观察组治疗期间不良反应发生率低于对照组,但差异无统计学意义(P>0.05).经治疗观察组生存质量GQOLI-74问卷评分值明显高于对照组(P<0.05).结论 对于老年急性髓系白血病患者的治疗,维奈克拉联合阿扎胞苷联合方案具有有效率高,安全性好的优势,可明显改善患者血液指标、免疫功能水平,改善预后质量,值得参考应用.
Analysis of the Therapeutic Effect of Vinecycline Combined with Azacytidine on Elderly Patients with Acute Myeloid Leukemia
Objective To analyze the clinical efficacy of vinecycline combined with azacitidine in the treatment of elder-ly patients with acute myeloid leukemia.Methods 86 elderly patients with acute myeloid leukemia were randomly divided into 2 groups using a random number table method(with 43 cases in each group).The observation group received treatment with Vine-clavone combined with Azacytidine,while the control group received treatment with Azacytidine alone.Results The total effective rate of clinical treatment in the observation group was higher than that in the control group(P<0.05);After treatment,the plate-let count and white blood cell count of the observation group were higher than those of the control group;And the proportion of bone marrow primitive cells was lower than that of the control group(P<0.05);After treatment,the levels of immune function in-dicators CD3+,CD4+,CD8+,CD4+/CD8+in the observation group were lower than those in the control group(P<0.05);The incidence of adverse reactions during treatment in the observation group was lower than that in the control group,but the difference was not statistically significant(P>0.05);After treatment,the GQOLI-74 questionnaire score for quality of life in the observation group was significantly higher than that in the control group(P<0.05).Conclusion Regarding the treatment of elderly patients with acute myeloid leukemia,the combination of vineclavone and azacitidine has the advantages of high effectiveness and good safety.It can significantly improve the patient's blood indicators,immune function levels,and prognosis quality,and is worth refer-ring to for application.

VinecalaAzacytidineElderly acute myeloid leukemiaImmune functionAdverse reactions

李卓、姚金晓、杨莹

展开 >

473000 河南省南阳市第二人民医院

维奈克拉 阿扎胞苷 老年急性髓系白血病 免疫功能 不良反应

2024

实用癌症杂志
江西省肿瘤医院 江西省肿瘤研究所

实用癌症杂志

影响因子:1.241
ISSN:1001-5930
年,卷(期):2024.39(6)